<
Online drug sales supervision becomes stricter and traditional pharmaceutical circulation enterprises will benefit
Release time: 2016-08-02 & nbsp & nbsp & nbsp Source: Anonymous
  From August 1st,Tmall Medical Museum stops online medicine。In addition,Many other well -known pharmaceutical network platforms will also suspend related business。Tmall Pharmaceutical Museum stake betting appis expressed stake sports betting appin a foreign statement,It will be notified in accordance with the Hebei Pharmaceutical Supervision Bureau,Actively cooperate with stopping third -party platform drug online retail business,Maintain normal operations in other businesses。Facts,The online drug sales platform has been collectively stopped。At the end of July,The State Food and Drug Administration announced that the pilot work of the third -party online drug sales platform has ended。
 
  It is understood,Starting last year,Drug circulation enterprises actively transform,Efforts to develop the pharmaceutical e -commerce market,Alibaba, with the advantages of traffic、Tencent、Baidu、JD.com and other Internet companies cross -border integration、Integrated resources,It has a profound impact on the changes in the industry's pattern。Medical e -commerce model also presents a diversified trend,If you work through a self -built platform or cooperate with pharmaceutical e -commerce companies,Development B2B、B2C、O2O business,Integrated supplier、My stake betting appWholesale Stake Sports BettingEnterprise、Retail pharmacy、Hospital resources to create a cloud service platform,Provide convenience services such as chronic disease health consultation through the cloud service platform,and cross -bank cooperation、Smart pharmaceutical information services in cross -region,Help users complete from self -diagnosis to consultation、The whole process of buying medicine。
 
  Statistics of the Ministry of Commerce,As of the end of last year,A total of 386 companies that have obtained pharmaceutical network retail B2C permits,The number increased by 46.2%compared to the previous year,and only 137 in the medical network retail B2C in 2013。
 
  Industry insiders think,Many problems exposed during the pilot period of third -party platform sales pilots,Especially the question of online sales prescription medicine,It may be the fundamental reason why the regulatory authorities are determined to stop。Another,Internet industry experts revealed to the information of the upper evidence,Security should be the main problem of online drug sales,Strict Stake Sports BettingMy stake betting appsupervision can also be understood,But from the perspective of the convenience of buying medicine,Online drug sales still have a large advantage。
 
  Facts,Tmall Medical Museum is called to stop the online transaction function of drugs,It may also take a similar way to shop,Only provide drug information display,After the consumer chooses the product required for selection,Page automatically jump to the official website of the corresponding pharmaceutical dealer to complete the transaction。But this will also bring an additional burden to the merchant,For example, an increase in labor cost、Decrease in transaction efficiency,In the end, it will affect the overall sales。Analysis of industry insiders believes,Online drug sales business is cold,It is expected to return to offline retail business,Traditional pharmaceutical distribution enterprises will get more development opportunities。